Effects of Sibutramine on Insulin Resistance, Metabolic Parameters and Abdominal Fat Mass
Turkiye Klinikleri Tip Bilimleri Dergisi, 2007
Objective: Obesity is recognized as a major worldwide health problem. In particular, visceral fat... more Objective: Obesity is recognized as a major worldwide health problem. In particular, visceral fat accumulation is usually accompanied by insulin resistance or type 2 diabetes mellitus, hyp ertension, hypertriglyceridemia, high uric acid and low high- density lipoprotein cholesterol levels defined as metabolic syndrome. M etabolic syndrome is strongly associated with increased risk of cardiovascular morbidity and mortality. The objective of this stud y wa s to assess the effects of sibutramine therapy on body mass ind ex (BMI), body fat distribution, visceral fat mass (VF) accum ulation, insulin resistance and plasma lipid profile in central obes e patients. Material and Methods: Demographic, biochemical and anthropometric measurements, i nsulin resistance that was calculated by using homeostasis model assessment of 43 obese patients treated with 15 mg/day sibutramine for 6 months were evaluated. Abdominal fat distributions were determined by ultrasound exa mination. Results: Sibutra...
Uploads
Papers by Nuran Sabir